from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3533c/PPE62

LFCtreatmentdescriptionclass of inhibitor

-0.910

Amikacinug/mL Amikacintranslation

-0.198

Cap5-10ug/mL Capreomycintranslation

0.069

Rox10-50 ug/mL Roxithromycintranslation

-0.273

SM2-5 ug/mL Streptomycintranslation

-1.680

Tet5-10 ug/mL Tetracyclinetranslation

-1.119

Rif0.2-5ug/mL Rifampicintranscription

-0.179

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.619

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.047

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.273

CPZ10-50 ug/mL Chlorpromazinerespiration

0.572

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.037

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.082

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.334

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.610

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.042

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.739

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.175

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.742

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.707

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.192

KCN5-20 ug/mL Potassium cyaniderespiration

0.028

NaN30.2-2 mM Sodium aziderespiration

1.666

Nigericin50 uM Nigericinrespiration

1.103

TRC10-150 ug/mL Triclosanrespiration

0.827

TRZ10-25 ug/mL Thioridazinerespiration

0.152

Valinomycin0.5-10 uM Valinomycinrespiration

0.338

ZnSO42 mM ZnSO4respiration

-0.612

menadione6-10 ug/mL Menadionerespiration

-0.272

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.478

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.669

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.157

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.733

NRP_1Non-replicating persistence stage 1dosRassociated

0.011

Amp0.2mg/mL AmpicillincellWall

-0.296

Cephalexin20-100 ug/mL CephalexincellWall

-0.256

Cerulenin0.32-5 ug/mL CerulenincellWall

0.216

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.313

EMB10-20 ug/mL EthambutolcellWall

-0.158

Eta12-40 ug/mL EthionamidecellWall

-0.354

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.419

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.158

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.069

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.106

BZA0.12 mg/mL BenzamidearomaticAmides

-0.147

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.032

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.652

H2O24 mM hydrogen peroxideDNAdamaging

-0.743

Levo10 ug/mL LevofloxacinDNAdamaging

-0.743

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.164

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.819

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.382

UVUV-irradiationDNAdamaging

-0.742

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.527

Antimycin12.5-50 ug/mL Antimycin A?

-0.114

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.801

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.367

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.964

PA8240.2-2 ug/mL PA-824?

-0.324

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.863

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

2.458

Verapamil50 uM Verapamil?

-0.425

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.061

methoxatin10-20 ug/mL Methoxatin?